Inossia Cement Softener - a new and unique additive to bone cements to revolutio...
Inossia Cement Softener - a new and unique additive to bone cements to revolutionise the treatment of vertebral fractures in osteoporotic patients
The Inossia Cement Softener is an additive (a softener) for bone cements that lowers their stiffness by 50-75% and adjusts it to that of the bone it is injected into. This does not alter the spinal biomechanics to the extent that...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
MAT2010-19431
BIOMATERIALES PARA CEMENTACION Y RESTAURACION DE HUESO OSTEO...
44K€
Cerrado
DPI2014-53401-C2-1-R
DISEÑO Y DESARROLLO DE UNA PLATAFORMA MULTIESCALA-INVITRO-IN...
191K€
Cerrado
DPI2014-53401-C2-2-R
DISEÑO Y DESARROLLO DE UNA PLATAFORMA MULTIESCALA-INVITRO-IN...
141K€
Cerrado
VitaDisc
A novel non-invasive therapy based on injectable viscous gel...
5M€
Cerrado
MAT2017-86043-R
DESARROLLO DE IMPLANTES DENTALES CON PROPIEDADES OSTEOGENICA...
115K€
Cerrado
Información proyecto SMART-SOFT
Duración del proyecto: 24 meses
Fecha Inicio: 2023-07-14
Fecha Fin: 2025-07-31
Líder del proyecto
INOSSIA AB
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
3M€
Descripción del proyecto
The Inossia Cement Softener is an additive (a softener) for bone cements that lowers their stiffness by 50-75% and adjusts it to that of the bone it is injected into. This does not alter the spinal biomechanics to the extent that the currently used cements do which in turn reduces the risk of new unnecessary vertebral fractures by 75%.
The Inossia Cement Softener has the potential to become a true game-changer and revolutionise the outcome of vertebral augmentation treatments in osteoporotic patients:
the patients will experience immediate pain relief, allowing them to go back to everyday life without the risk of rehospitalization,
the clinicians will be able to offer an efficient treatment
the healthcare payers will save money previously unnecessary spent on the retreatment of already treated patients
Our innovation is designed to revolutionise the treatment of osteoporosis, ensuring a healthy and active ageing.